CIMS - ECMI

CANADIAN INFLAMMATORY MYOPATHY STUDY  - ÉTUDE CANADIENNE SUR LES MYOPATHIES INFLAMMATOIRES

Peer-reviewed manuscripts

Maliha PG, Hudson M, Abikhzer G, Singerman J, Probst S. 18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications. Nucl Med Commun. 2019;40(4):377-82.

Anh-Tu Hoa S, Hudson M. Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2017;46(4):488-508.

 Greenfield J, Hudson M, Vinet E, Fortin PR, Bykerk V, Pineau CA, et al. A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs). PLoS One. 2017;12(12):e0189840.

 Leclair V, Regardt M, Wojcik S, Hudson M, (CIMS) CIMS. Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review. PLoS One. 2016;11(8):e0160753.

 Letters & brief reports

Leclair V, Landon-Cardinal O, Hudson M. Letter in response to 'Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors'. Eur J Cancer. 2019;112:47-8.

 Landon-Cardinal O, Prince F, Bédard S, Benveniste O, Hudson M. Dermoskeletics to preserve mobility and function in inclusion body myositis. Neurology. 2018;91(16):760.

 Published abstracts

Meyer A, Leclair V, Landon-Cardinal O, Ellezam B, D’Aoust J, Giannini M et al. ACR/EULAR Criteria for Myositis and Systemic Sclerosis Lack Sensitivity for Scleromyositis. American College of Rheumatology Annual Meeting, 2019 ACR/ARP; Atlanta, GA: Arthritis and Rheumatism; 2019. p. 629-31. 

 D’Aoust J, Leclair V, Gyger G, Meyer A, Fritzler M, Landon-Cardinal O et al.  Autoantibody Profiles Delineate Three Distinct Subsets of Scleromyositis. American College of Rheumatology Annual Meeting, 2019 ACR/ARP; Atlanta, GA: Arthritis and Rheumatism; 2019. p. 653-4.  

 Bangert E, Hudson M, Vinet E, Wang M, Gyger G. Nailfold videocapillaroscopy in idiopathic inflammatory myopathies. 73rd Annual Meeting of the Canadian Rheumatology Association, CRA 2018; Vancouver, BC, Canada: Journal of Rheumatology; 2018. p. 1024.

 Assayag D, Hirsch A, Baron M, Vinet E, Albert A, Fortin P, et al. Extensive interstitial lung disease in inflammatory myopathy is a strong predictor of mortality.  European Respiratory Society International Congress; Milan, Italy: European Respiratory Journal; 2017.

Cafaro T, Leclair V, Wang M, Baron M, Fritzler M, Hudson M. Incident autoimmune myositis in systemic sclerosis – results of a longitudinal study. 72nd Annual Meeting of the Canadian Rheumatology Association, CRA 2017; Ottawa, ON, Canada: Journal of Rheumatology; 2017. p. 876. 

 Assayag D, Hirsch A, Baron M, Hudson M, Canadian Inflammatory Myopathy Study Group. Radiographic and physiologic abnormalities in subjects with myositis-associated interstitial lung disease. American Thoracic Society Conference 2016; San Francisco, California: American Journal of Respiratory and Critical Care Medicine 2016;193:A1152.

 Leclair V, Vinet E, Albert A, Fortin P, Wang M, Baron M, Hudson M. Health-related quality of life in early idiopathic inflammatory myopathy. 71st Annual Meeting of the Canadian Rheumatology Association, CRA 2016; Québec, QC, Canada: Journal of Rheumatology; 2016. p. 1229.

 Basharat P, Wang M, Venance S, Nicolle M, Hudson M. Intravenous immunoglobulin for the treatment of idiopathic inflammatory myopathies – A survey of Canadian physicians. 71st Annual Meeting of the Canadian Rheumatology Association, CRA 2016; Québec, QC, Canada: Journal of Rheumatology; 2016. p.1233-34. 

 Greenfield J, Hudson M, Pineau C, Vinet E, Fortin P, Bykerk V, Tatibouet S, Taillefer S, Baron M, Bernatsky S. Health-related quality of life (HRQoL across systemic autoimmune rheumatic diseases (SARDS). 69th Annual Meeting of the Canadian Rheumatology Association, CRA 2014; Whistler, BC, Canada: Journal of Rheumatology; 2014. p. 1469-70.